First Trust Nasdaq Pharmaceuticals ETF
FTXH
FTXH
22 hedge funds and large institutions have $7.55M invested in First Trust Nasdaq Pharmaceuticals ETF in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$611K | |
| 2 | +$549K | |
| 3 | +$401K | |
| 4 |
Morgan Stanley
New York
|
+$170K |
| 5 |
NB
NBT Bank
Norwich,
New York
|
+$21.5K |
Top Sellers
| 1 | -$536K | |
| 2 | -$534K | |
| 3 | -$530K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$346K |
| 5 |
SPIA
Steward Partners Investment Advisory
New York
|
-$272K |